LEADING PROVIDER OF GENERIC DRUGS IN HONG KONG
We are leading API suppliers and exporters with products ranging from APIs, Finished Formulations, Critical Raw Materials, Advanced Intermediates, and Impurities. Apotex has extensive years of invaluable experience in the global pharmaceutical industry and is present in more than 40 countries across Asia, Europe, Africa, North America, and South America. We are an ISO-compliant company with approvals such as WHO-GMP, KFDA, PMDA, EU-GMP, USFDA, etc.
Mission & Vision
OUR VISION
To be the preferred strategic partner for the pharmaceutical industry supplying Active Pharmaceutical Ingredients, Advanced Intermediates and Speciality fine chemicals, which are based on innovative ideas and robust technology.
OUR MISSION
Our mission is to achieve worldwide recognition as an excellent business partner from Hong Kong by providing our customers with superior quality products at highly affordable prices, coupled with consistent provision of reliable services in order to give our customers an unparalleled experience. We also believe strongly in creating a healthy and nurturing environment for all over employees.
marketing solutions provider
WE ARE DRIVEN BY INNOVATION
Apotex Limited Is An ISO 9001:2015, ISO 14001:2015 and OSHAS 18001:2008 Certified Organization Is A Well-Informed, Highly Efficient, Swiftly Functioning Competitive Pharmaceutical Research, Manufacturing, And Sourcing Company. We Serve Private, Institutional, And Corporate Clients Worldwide In The Field Of Pharmaceuticals & Nutraceuticals. We Combine Our Contacts, Their Expertise, And Core Competency With Our Operations To Deliver Superior Pharmaceutical Sourcing Solutions To Our Customers. Having Our Base In Hong Kong and India Apotex Limited Has Been Serving Clients In More Than 73 Countries. We Are Able To Synthesize Newer APIs ( Active Pharmaceutical Ingredients, Active Pharmaceutical Raw Materials ) And Their Advance Pharmaceutical Intermediates In Highly Efficient Network Facilities In India and China. Many of our projects were Successfully Initiated To The Buyer’s Satisfaction And Concluded Along With the Submission Of Technical Documentation As Required For Drug Master File (DMF) Filing. Very Many Other Projects For Synthesizing Api’s Or Synthesizing Cumbersome Intermediates And Molecules Are Under Progress In Different Stages From Initial Route Scouting And Synthesis To Commercialization.
